V5 assembles the deviation evidence, drafts the description, proposes candidate root causes with a 5-Why or fishbone, and stubs the corrective and preventive action plans. The investigator's job is to challenge and approve — not to compose from scratch.
80% of investigator time is spent typing narrative, not investigating.
5-Why and fishbone become box-ticking because filling them from a blank template is slow.
Verification steps get copy-pasted across CAPAs, weakening the effectiveness gate.
V5 pulls the deviation, associated batch data, prior similar cases and the operator interview transcript into a first-pass narrative — with confidence and citations.
5-Why chains and fishbone branches proposed against precedent — investigator confirms, edits or rejects with reason.
Similar closed CAPAs surface as reference so the plan builds on what worked, not what was fastest to write.
Effectiveness plan proposed per action type (SOP change, retraining, equipment fix) — not a generic checkbox.
Human approval, e-signature and effectiveness verification all remain human-in-the-loop. AI drafts; people decide.
AI drafting is a productivity feature — but only if effectiveness stays human-owned. Criteria that keep both true.
What it tests: Are drafts built from the actual source records, not from generic templates?
Why it matters: Generic drafts read as generic and fail effectiveness.
V5: Drafts anchored to the deviation, batch, prior CAPAs and interview transcript.
What it tests: Are candidate causes ranked with rationale, or one prose paragraph?
Why it matters: Ranking makes the investigator's challenge specific.
V5: 5-Why and fishbone with per-branch citations.
What it tests: Is the effectiveness plan tailored to the action type?
Why it matters: Generic verifications are how CAPAs get reopened.
V5: Per-action-type verification proposal.
What it tests: Is closure structurally blocked without human sign-off?
Why it matters: Autonomous closure is a Part 11 violation.
V5: Approval, signature and closure all human.
What it tests: Are similar closed CAPAs surfaced during drafting?
Why it matters: The best draft learns from what worked.
V5: Precedent surfaced with outcome data.
What it tests: Is every AI-drafted claim traceable to its source and to reviewer attestation?
Why it matters: Auditor test.
V5: Full trail from source → draft → reviewer approval.
AI-assisted CAPA drafting vs pure-human drafting vs generic AI writing tools.
| Capability | Spreadsheet | Legacy QMS | V5 Ultimate |
|---|---|---|---|
| Evidence anchoring | N/A | N/A | Native |
| Ranked causes | Manual | Free-form | Ranked with rationale |
| Precedent surfaced | Memory | Rare | Automatic |
| Verification tailored | Boilerplate | Often generic | Per action type |
| Closure human | Yes | Yes | Yes (structurally enforced) |
The CAPA clauses that AI drafting must respect.
Each manufacturer shall establish and maintain procedures for implementing corrective and preventive action.
V5: AI drafts within the SOP-defined CAPA lifecycle — it does not create a parallel path.
Identifying the action(s) needed to correct and prevent recurrence.
V5: AI proposes; investigator confirms; effectiveness proves.
The pharmaceutical quality system should include the following elements: ...corrective action and preventive action (CAPA) system.
V5: CAPA remains the record; AI accelerates authorship.
Use of appropriate controls over systems documentation.
V5: AI model version, prompt template and output are documented and version-controlled.
AI drafting rolls out in three stages so QA governance keeps pace.
AI summarises the deviation for the investigator — no drafting yet.
AI drafts on-demand at investigator request.
Every new CAPA opens with a drafted first pass; investigator challenges and approves.
QA samples AI-drafted CAPAs for quality-of-reasoning review.
ROI shows as investigator throughput and CAPA cycle time — not as headcount cuts.
Investigator challenges instead of composes.
Cycle shrinks around the removed drafting bottleneck.
Action-typed verification proposal beats boilerplate.
The value is investigator time reallocated to investigation — not fewer investigators.
Setting
A biologics site with a 30-person QA / investigations team and a 90-day CAPA backlog.
Before
New CAPAs took an average of 61 days to close; investigators reported drafting as the biggest time-sink.
After
Six months in, average cycle-time is 26 days; backlog cleared; investigator satisfaction up materially and effectiveness-gate reopens down.
No. Draft is AI; approval, signature and effectiveness verification are always human. This is a Part 11 requirement, not a preference.
Every drafted claim carries the record it came from and the reviewer's attestation of accuracy at approval time — auditable end-to-end.
Per-tenant and per-user. Sites in the middle of validation typically turn it on read-only first, then on-draft, then on-suggest — one gate at a time.
Free trial, no card. Live in 7 days with guided onboarding.